Bausch & Lomb (BLCO) Cash from Investing Activities (2021 - 2026)

Bausch & Lomb (BLCO) posted Cash from Investing Activities of -$130.0 million for Q1 2026, up 30.85% on a QoQ basis from -$188.0 million in Q4 2025, and down 12.07% year-over-year from -$147.8 million in Q1 2025.

Bausch & Lomb (BLCO) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Bausch & Lomb's Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$130.0 million for Q1 2026.

  • Quarterly Cash from Investing Activities fell 12.07% year-over-year to -$130.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$469.0 million (changed 0.42% YoY) and the FY2025 annual result came in at -$455.0 million, down 10.44% from the prior year.
  • Cash from Investing Activities was -$130.0 million for Q1 2026 at Bausch & Lomb, up from -$188.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$28.0 million in Q2 2023 and bottomed at -$1.9 billion in Q3 2023.
  • A 5-year average of -$195.4 million and a median of -$90.0 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 3740.82% — and 2024, when it surged 94.9%.
  • Bausch & Lomb's Cash from Investing Activities stood at -$90.0 million in 2022, then plunged by 50.0% to -$135.0 million in 2023, then plunged by 37.04% to -$185.0 million in 2024, then dropped by 1.62% to -$188.0 million in 2025, then surged by 30.85% to -$130.0 million in 2026.
  • Business Quant data shows BLCO's Cash from Investing Activities at -$130.0 million in Q1 2026, -$188.0 million in Q4 2025, and -$61.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -139.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn -218.00 Mn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn -96.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn -58.03 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn -43.20 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn -77.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -90.00 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn -131.58 Mn
10 Bausch & Lomb 5.79 Bn 5.51 Bn 973.00 Mn -130.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -130.00 Mn
Mar 31, 2026 -130.00 Mn
Dec 31, 2025 -188.00 Mn
Dec 31, 2025 -188.00 Mn
Sep 30, 2025 -61.00 Mn
Sep 30, 2025 -61.00 Mn
Jun 30, 2025 -90.00 Mn
Jun 30, 2025 -90.00 Mn
Mar 31, 2025 -116.00 Mn
Mar 31, 2025 -116.00 Mn
Dec 31, 2024 -185.00 Mn
Dec 31, 2024 -185.00 Mn
Sep 30, 2024 -96.00 Mn
Sep 30, 2024 -96.00 Mn
Jun 30, 2024 -74.00 Mn
Jun 30, 2024 -74.00 Mn
Mar 31, 2024 -57.00 Mn
Mar 31, 2024 -57.00 Mn
Dec 31, 2023 -135.00 Mn
Dec 31, 2023 -135.00 Mn